InvestorsHub Logo
Followers 21
Posts 635
Boards Moderated 0
Alias Born 11/08/2018

Re: Whalatane post# 380879

Sunday, 06/19/2022 2:25:15 PM

Sunday, June 19, 2022 2:25:15 PM

Post# of 425775
Kiwi
Health net case - Amarin can only settle this case on the same basis as if they had won it at trial - and health net won’t agree that

Why?? Because

Amarin need to win it as it wants to enforce the cvd patents on ALL of the other Health-net equivalents in the USA - to in effect restore the cvd market - by sending out the message - you supply generics on cvd basis and we will sue your ass - look what we did to Healthnet - we destroyed them - we will destroy you as well … so back off our cvd market

Settle this achieves nothing if it is on wishy washy terms that lets the others off the hook

I don’t see the heath net case as a big play in all of this following Hikma ruled out by the judge Andrews -and Amarin can’t appeal that decision (I believe ) until Healthnet alone case is concluded - so it’s a years off / will an appeal succeed ?/it’s in the long grass -as far as hickma is concerned

The only litigation of immediate help is Supreme Court Marjac Epadi - certiorari

And that is a moonshot

We have what we have - declining USA sales - so cut costs to the bone - long delay before. Income in Europe / so cut costs in Europe to the bone - and make damn sure this present board is out and not lining their option pockets

Amarin is very saleable - some cash in bank / great tax lossses / some income USA - great income potential Europe Row / other applications for drug ahead

A big scale pharma company can make money out of vascepa

Amarin can not -

The present board and present plans will leave company profit less and cash reducing for several years to come

Denner I feel want this done in 12 months - he has been in it for nearly a year already

There will be fireworks

His outcome is a sale of the company in 12 months
He would be happy to get 10 dollars a share and get out of it as quickly as he can

Interesting question - Will he buy more shares at these reduced prices

Such would
Raise the share price - as would his emerging plans / control takeover of the company

And position the company to be a 10 dollar equivalent sale for him.

Sarrisa risk is they don’t pull it off ….

I see them succeeding

Good to exchange views again kiwi and best wishes to you and all on the board

Final comment for now

I have read Marjacs brief to Supreme Court

It is a masterpiece

It tell it exactly as it is

The Du decision was a travesty of American justice. It has destroyed Amarin as a company -destroyed the assets of its shareholders and destroyed Vascepa in the USA as a life saving patient treatment

Will the Supreme Court act ????????

Let hope we get to the moon
Alm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News